Aurinia Pharmaceuticals

About:

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Website: http://www.auriniapharma.com/

Twitter/X: AuriniaPharma

Top Investors: RA Capital Management, New Enterprise Associates, Apple Tree Partners, Lumira Ventures, Redmile Group

Description:

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.